ResearcherNiğde Ömer Halisdemir ÜniversitesiActive in the last 2 years

Fatih Yay

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1872-8716; OpenAlex author ID A5047189285. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

NECTIN4 (PVRL4) expression in pancreatic cancer patients might be associated with a more unfavorable prognosis, independent of age at diagnosis, sex, and stage… Co-author DOI 10.1016/j.compbiolchem.2026.109306 ↗
Dynamine 3 as a diagnostic and prognostic biomarker in pancreatic cancer: Implications for early detection and targeted therapy. Co-author DOI 10.1080/1354750x.2025.2458104 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Meltem Uyaner Kan · 1 shared paper, 2026 · strength 0.63
- Paper NECTIN4 (PVRL4) expression in pancreatic cancer patients might be associated with a more unfavorable prognosis, indepen… DOI 10.1016/j.compbiolchem.2026.109306 ↗
Hasan Çağrı Yıldırım · 1 shared paper, 2025 · strength 0.37
- Paper Dynamine 3 as a diagnostic and prognostic biomarker in pancreatic cancer: Implications for early detection and targeted… DOI 10.1080/1354750x.2025.2458104 ↗
Şuayib Yalçın · 1 shared paper, 2025 · strength 0.37
- Paper Dynamine 3 as a diagnostic and prognostic biomarker in pancreatic cancer: Implications for early detection and targeted… DOI 10.1080/1354750x.2025.2458104 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.